| Aug 20 |
37% Of This Johnson & Johnson Insider's Holdings Were Sold
|
| Aug 20 |
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) approved in the U.S. as a first-line chemotherapy-free treatment for patients with EGFR-mutated advanced lung cancer
|
| Aug 19 |
5 Dividend Growth Stocks to Buy and Hold Forever
|
| Aug 19 |
Histosonics raises $102M for noninvasive treatment to destroy tumors
|
| Aug 18 |
2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade
|
| Aug 17 |
J&J, Roche come out on top in S&P ratings of strongest pharma companies
|
| Aug 16 |
Why Is Johnson & Johnson (JNJ) Up 2.4% Since Last Earnings Report?
|
| Aug 15 |
These 10 drugs will be cheaper after Medicare negotiations
|
| Aug 15 |
Update: US Government Sets Out Prices of 10 Drugs in Medicare Negotiations
|
| Aug 15 |
US Government Sets Out Prices of 10 Drugs in Medicare Negotiations
|
